Skip to main content
. 2012 Apr 18;2012(4):CD003869. doi: 10.1002/14651858.CD003869.pub3

Postmus 2000

Methods RCT enrolled: 134 evaluated: 120
Participants Inclusion: 1. metastatic small cell lung cancer 2. brain metastases (CT) 3. extracranial tumour 4. no previous treatment with chemotherapy or radiation for brain metastases 5. no prior teniposide 6. age less than 76 years Exclusion: 1. uncontrolled infection 2. serious non‐malignant disease
Interventions teniposide chemotherapy with or without WBRT
Outcomes 1. Survival 2. Time to progression 3. Duration of response
Notes QS =1